Calcimedica Inc

CUSIP 38942Q202COM NEWCALCQ1 2026

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

18.9%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

35 filings · latest Feb 6, 2026

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Feb 6, 2026	Deerfield Mgmt, L.P.	13G/A	4.3%	653.3K	SEC
2	Dec 1, 2025	Chernett Jorey	13G	7.9%	1.13M	SEC
3	Nov 7, 2025	Soleus Private Equity Fund III, L.P.	13G/A	7.5%	1.08M	SEC
4	Oct 29, 2025	Bering Partners II, L.P. ("Bering II")	13G	11.0%	663.2K	SEC
5	Sep 9, 2025	Avenue Venture Opportunities Fund II, L.P.	13G/A	8.9%	1.36M	SEC
6	Sep 2, 2025	Avenue Venture Opportunities Fund II, L.P.	13G/A	8.9%	1.36M	SEC
7	Aug 5, 2025	Alafi Capital Company, LLC	13G/A	11.3%	1.58M	SEC
8	May 28, 2025	Avenue Venture Opportunities Fund II, L.P.	13G	6.7%	1.00M	SEC
9	May 14, 2025	Stonepine Capital Management, LLC	13G/A	4.6%	—	SEC
10	Apr 1, 2025	Alafi Capital Company, LLC	13G	9.6%	1.30M	SEC

See the full Schedule 13D/13G history for Calcimedica Inc.

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Jane Street Group, LLC	178.5K	$96.4K
2	Renaissance Technologies LLC	128.1K	$69.2K
3	180 Wealth Advisors, LLC	126.5K	$68.3K
4	Geode Capital Management, LLC	123.4K	$66.7K
5	Stonehage Fleming Financial Services Holdings Ltd	53.7K	$29.0K
6	Susquehanna International Group, LLP	30.7K	$16.6K
7	State Street Corp	17.1K	$9.2K
8	Tritonpoint Partners, LLC	15.1K	$8.2K
9	First Manhattan Co. LLC.	13.2K	$7.1K
10	Simplex Trading, LLC	12.8K	$6.9K